Zhiguang Chen

Dr. Zhiguang Chen


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2025 in Advanced Science
Verified
Journal Article
Open access
ZCZhiguang Chen
Zhiguang Chen
LSLiang Sang
Liang Sang
YLYanjun Liu
Yanjun Liu
ZBZhiQun Bai
ZhiQun Bai
Sonodynamic therapy (SDT) represents a promising approach for cancer treatment. Compared to photodynamic therapy, SDT offers increased penetration depth and higher precision. However, the practical application of SDT is constrained by the low water solubility, poor tumor specificity, and metabolic susceptibility of most sonosensitizers. Recent research has explored the use of piezoelectric materials as sonosensitizers in cancer treatment and inhibition of bacterial growth. Upon ultrasound excitation, the separation of electron–hole (e−–h+) pairs occurs within the piezoelectric material. By improving the crystal structure of the material or incorporating other nanoparticles to prevent rapid recombination of e−–h+ pairs, the piezoelectric material accumulates charges in the conduction band and valence band, achieving the redox potential of O2/·O2−. This enables the piezoelectric material to serve as a sonosensitizer, leading to the concept termed Sono‐Piezo Dynamic Therapy (SPDT). This review aims to define the concept of SPDT, provide a systematic overview of the historical development of piezoelectric materials in the application of SDT, and elucidate the potential mechanisms by which piezoelectric materials act as sonosensitizers. Importantly, various piezoelectric materials will be discussed in terms of their feasibility, advantages, and disadvantages as sonosensitizers, offering new perspectives for identifying potential sonosensitizers.

17 March 2025 in Materials Today Bio
Verified
Journal Article
Open access
ZCZhiguang Chen
Zhiguang Chen
LSLiang Sang
Liang Sang
QZQixi Zhai
Qixi Zhai
XLXiang Li
Xiang Li
YLYanjun Liu
Yanjun Liu
ZBZhiQun Bai
ZhiQun Bai
Central nervous system (CNS) cancers, particularly glioblastoma (GBM), are associated with high mortality and disability rates. Despite aggressive surgical resection, radiotherapy, and chemotherapy, patient survival remains poor. The blood-brain barrier (BBB) significantly impedes therapeutic efficacy, making BBB penetration a critical focus of research. Focused ultrasound (FUS) combined with microbubbles (MBs) can transiently open the BBB through mechanisms such as cavitation, modulation of tight junction protein expression, and enhanced vesicular transport in endothelial cells. This review highlights precision delivery and personalized treatment strategies under ultrasound visualization, including precise control of ultrasound parameters and modulation of the immune microenvironment. We discuss the applications of ultrasound-responsive nanoparticles in brain tumor therapy, including enhanced radiotherapy, gene delivery, immunotherapy, and sonodynamic therapy (SDT), with a particular emphasis on piezoelectric catalytic immunotherapy. Finally, we provide insights into the clinical translation potential of ultrasound-responsive nanoparticles for personalized and precision treatment of brain tumors.

10 November 2023 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
ZCZhiguang Chen
Zhiguang Chen
LYLizhi Yang
Lizhi Yang
ZYZhimin Yang
Zhimin Yang
Zihua WangZihua Wang
Zihua Wang
WHWen He
Wen He
WZWei Zhang
Wei Zhang

24 October 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
YYYuting Yang
Yuting Yang
YCYuan Cheng
Yuan Cheng
ZCZhiguang Chen
Zhiguang Chen
YLYanjun Liu
Yanjun Liu
Ultrasound-responsive micro/nanobubbles (MNBs) are promising tools for targeted cancer therapy due to their controllable acoustic activation and real-time imaging. Despite extensive research, the quantitative relationship between bubble structure, acoustic response, and therapeutic efficacy remains poorly understood. This knowledge gap hinders parametric design and clinical standardization. This review summarizes recent advances from an engineering perspective, highlighting how structural parameters—such as size, shell, gas core, and ligand density—affect acoustic sensitivity and drug release. Furthermore, the roles of microfluidic electroporation and cell membrane coating are discussed in terms of controllable fabrication and preservation of biological functions, highlighting their significance for reproducible and predictable therapies. In conclusion, this review establishes a “Structure-Response-Efficacy (S-R-E)” framework to summarize the core relationships between structural design and acoustic modulation. We propose an engineering strategy based on a standardized parameter system to guide the predictable design and clinical translation of ultrasound-based theranostic platforms.

3 August 2020 in Cancer Imaging
Verified
Journal Article
Open access
PDF file
ZCZhiguang Chen
Zhiguang Chen
LSLiang Sang
Liang Sang
YZYixia Zhang
Yixia Zhang
DBDonglin Bian
Donglin Bian
ZCZhiguang Chen
Zhiguang Chen
XWXuemei Wang
Xuemei Wang
Objective: To establish Greater Omentum Imaging-Reporting and Data System (GOI-RADS) to evaluate the possibility of omental diseases being malignant. Method: A retrospective analysis was made of 883 patients who had undergone biopsy of the greater omentum in our center from October 2009 to October 2019. Twelve parameters of ultrasonographic images were evaluated, and the odds ratio of each group calculated. We assigned scores for the direct signs (omental echo, omental structure, and omental nodules) and indirect signs (separation of ascites, echo of ascites, mesenteric lymph nodes, and thickening of parietal peritoneum) of omental lesions. We created an omental score (OS) for each patient and receiver operating characteristic (ROC) curve to analyze its effectiveness in the differential diagnosis of benign and malignant omental diseases. Results: The OS was divided into ≤5, 6, 7, 8, 9, 10, 11, 12, 13, and ≥ 14 points, and the malignant rate was 0, 1.85, 5.56, 30.36, 37.25, 87.72, 96.72, 98.28, 99.08, and 100%, respectively. The area under the ROC curve (AUC) was 0.976. When taking 10 points as the cutoff value to diagnose benign and malignant omental diseases, the sensitivity and specificity was 93.85 and 98.21%, respectively. A grading system was established: grade 1: omental score ≤ 5, malignant rate 0%; grade 2: omental score 6–7, malignant rate ≤ 5.56%; grade 3: omental score 8-–9, malignant rate ≤ 37.25%; grade 4: omental score ≥ 10, malignant rate ≥ 87.72. Conclusion: GOI-RADS had high sensitivity and specificity in the differential diagnosis of benign and malignant omental lesions. We believe that GOI-RADS will aid the diagnosis of omental diseases based on objective and accurate interpretation of ultrasound features, and also to promote the ultrasonography of omental diseases in clinical application.

27 March 2025 in European Radiology
Verified
Journal Article
Closed access
PDF file
ZCZhiguang Chen
Zhiguang Chen
ZBZhiqun Bai
Zhiqun Bai
PYPuxu Yang
Puxu Yang
LSLiang Sang
Liang Sang
XLXiang Li
Xiang Li
YLYanjun Liu
Yanjun Liu